SCHEMBL692238

SCHEMBL692238

O=S(=O)(Cl)c1ccc2onc(Cl)c2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
FAAH O00519 1/20 0.35
PKM P14618 2/20 0.35
ALPL P05186 1/20 0.35
ALPI P09923 1/20 0.35
S1PR1 P21453 1/20 0.33
NPC1 O15118 1/20 0.33
CA12 O43570 3/20 0.33
CA1 P00915 3/20 0.33
CA2 P00918 3/20 0.33
CA9 Q16790 3/20 0.33
MAPT P10636 3/20 0.33
CA3 P07451 2/20 0.33
CA4 P22748 2/20 0.33
CA6 P23280 2/20 0.33
CA5A P35218 2/20 0.33
CA7 P43166 2/20 0.33
CA13 Q8N1Q1 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL692261 0.81 BRD4 (0.46) KMT2A
SCHEMBL8349122 0.81 ALPL (0.37) ALDH1A1HSD17B10TDP1PKMALPL
SCHEMBL6833044 0.81 PTPN1 (0.36) ALDH1A1HSD17B10TDP1FAAHPKM
SCHEMBL691641 0.78 LMNA (0.39) ALDH1A1HSD17B10TDP1PKMALPL
SCHEMBL12975343 0.78 BRD4 (0.38) ALDH1A1HSD17B10TDP1PKMALPL
SCHEMBL4378995 0.74 MAPT (0.39) ALDH1A1HSD17B10TDP1PKMALPL
SCHEMBL6989194 0.74 FAAH (0.51) ALDH1A1HSD17B10FAAHMAPTSMN1; SMN2
SCHEMBL6525933 0.74 L3MBTL1 (0.51) ALDH1A1HSD17B10TDP1PKMALPL
SCHEMBL692169 0.73 MAPT (0.47) NPC1MAPTSMN1; SMN2LMNAKMT2A
SCHEMBL6593057 0.71 LMNA (0.46) ALDH1A1HSD17B10TDP1NPC1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2422780-A1 Resistance-repellent retroviral protease inhibitors Sequoia Pharmaceuticals, Inc. (US) 2012-02-29 EP disclosed
EP-2422781-A1 Resistance-repellent retroviral protease inhibitors Sequoia Pharmaceuticals, Inc. (US) 2012-02-29 EP disclosed